Publication | Closed Access
Targeted delivery of a novel peptide–docetaxel conjugate to MCF-7 cells through neuropilin-1 receptor: reduced toxicity and enhanced efficacy of docetaxel
17
Citations
20
References
2015
Year
Neuropilin-1 ReceptorCell DeathPeptide ScienceTherapeuticsNrp-1 Negative CellsAnti-cancer AgentNovel TherapyCell-based Drug DeliveryBreast Cancer CellsCancer TreatmentPharmacologyCell BiologyDrug TargetingMcf-7 CellsPeptide TherapeuticDrug Delivery SystemsMedicineNovel Peptide–docetaxel ConjugateDrug Discovery
A novel peptide docetaxel conjugate selectively kills NRP-1 overexpressing breast cancer cells, enhances anticancer activity of docetaxel without affecting the NRP-1 negative cells.
| Year | Citations | |
|---|---|---|
Page 1
Page 1